Video

Ofatumumab vs Teriflunomide: Phase 3 ASCLEPIOS I/II Open-Label Extension Study

Author(s):

Mark Freedman, MD, MSc, HBSc, CSPQ, FANA, FAAN, FRCPC,Robert Naismith, MD

Newsletter

Keep your finger on the pulse of neurology—subscribe to NeurologyLive for expert interviews, new data, and breakthrough treatment updates.

Subscribe Now!
Related Videos
Sam Hooshmand, DO
Funke Afolabi-Brown, MD, FAASM
Brenda L. Wong, MD
Kevin Sheth, MD
Kevin Swong, MD
Related Content
Mendelian Randomization Analysis Identifies Neuroprotective and At-Risk Proteins for NMOSD
June 17th 2025

Mendelian Randomization Analysis Identifies Neuroprotective and At-Risk Proteins for NMOSD

Marco Meglio
Episode 142: World MS Day: Raising Awareness, Evolving Care, and Empowering Patients
May 30th 2025

Episode 142: World MS Day: Raising Awareness, Evolving Care, and Empowering Patients

Marco Meglio Taylor Hess, MD
Deepa Burman, MD, FAASM (Credit: UPMC)
June 16th 2025

Understanding Pediatric Insomnia: Risk Factors, Clinical Diagnosis, and Care Management

Deepa Burman, MD, FAASM Isabella Ciccone, MPH
Episode 140: Down Syndrome and Alzheimer’s: Clinical Trials, Equity, and Patient-Centered Progress
May 2nd 2025

Episode 140: Down Syndrome and Alzheimer’s: Clinical Trials, Equity, and Patient-Centered Progress

Marco Meglio Elizabeth Head, PhD
NeurologyLive® Friday 5 — June 13, 2025
June 13th 2025

NeurologyLive® Friday 5 — June 13, 2025

NeurologyLive® Staff
Funke Afolabi-Brown, MD, FAASM (Credit: Restful Sleep MD)
June 13th 2025

Looking at the Importance of Family-Centered Care Approaches in Pediatric Sleep Medicine

Funke Afolabi-Brown, MD, FAASM Isabella Ciccone, MPH
© 2025 MJH Life Sciences

All rights reserved.